These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Emergence of spatial impairment in rats following specific cholinergic depletion of the medial septum combined with chronic stress. Craig LA; Hong NS; Kopp J; McDonald RJ Eur J Neurosci; 2008 May; 27(9):2262-71. PubMed ID: 18445217 [TBL] [Abstract][Full Text] [Related]
48. Nerve Growth Factor Is Responsible for Exercise-Induced Recovery of Septohippocampal Cholinergic Structure and Function. Hall JM; Gomez-Pinilla F; Savage LM Front Neurosci; 2018; 12():773. PubMed ID: 30443202 [TBL] [Abstract][Full Text] [Related]
49. Altered NGF response but not release in the aged septo-hippocampal cholinergic system. Williams B; Nelson M; Granholm AC; Coultrap S; Browning M; Curtis M Exp Neurol; 2005 Nov; 196(1):30-40. PubMed ID: 16137678 [TBL] [Abstract][Full Text] [Related]
50. Differential role of entorhinal and hippocampal nerve growth factor in short- and long-term memory modulation. Walz R; Roesler R; Reinke A; Martins MR; Quevedo J; Izquierdo I Braz J Med Biol Res; 2005 Jan; 38(1):55-8. PubMed ID: 15665989 [TBL] [Abstract][Full Text] [Related]
51. GPR40 receptor activation leads to CREB phosphorylation and improves cognitive performance in an Alzheimer's disease mouse model. Khan MZ; Zhuang X; He L Neurobiol Learn Mem; 2016 May; 131():46-55. PubMed ID: 26976092 [TBL] [Abstract][Full Text] [Related]
52. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Lad SP; Neet KE; Mufson EJ Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):315-34. PubMed ID: 14529363 [TBL] [Abstract][Full Text] [Related]
53. Long term changes in brain cholinergic markers and nerve growth factor levels after partial immunolesion. Gu Z; Yu J; Perez-Polo JR Brain Res; 1998 Aug; 801(1-2):190-7. PubMed ID: 9729378 [TBL] [Abstract][Full Text] [Related]
54. Lentiviral-mediated overexpression of nerve growth factor (NGF) prevents beta-amyloid [25-35]-induced long term potentiation (LTP) decline in the rat hippocampus. Uzakov SS; Ivanov AD; Salozhin SV; Markevich VA; Gulyaeva NV Brain Res; 2015 Oct; 1624():398-404. PubMed ID: 26254730 [TBL] [Abstract][Full Text] [Related]
55. Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease. Rattray M Biol Psychiatry; 2001 Feb; 49(3):185-93. PubMed ID: 11230869 [TBL] [Abstract][Full Text] [Related]